Vimizim
Elosulfase alfa · BioMarin Pharmaceutical Inc.
PRESCRIPTION ONLY (USA)Vimizim ingredients
| Active ingredient | Strength |
|---|---|
| Elosulfase Alfa | 5 mg/5mL |
What Vimizim is used for
Vimizim is a specialist medicine (hydrolytic lysosomal glycosaminoglycan-specific enzyme). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Vimizim
- Generic name
- Elosulfase alfa
- Made by
- BioMarin Pharmaceutical Inc.
- Forms
- Injection, Solution, Concentrate
- Given
- Intravenous
- Drug class
- Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme
- FDA approval
- Biologic licence (BLA) BLA125460
- On the US market since
- 2014
Official information
- Vimizim prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Elosulfase alfa)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Vimizim?
Vimizim (Elosulfase alfa) is a specialist medicine made by BioMarin Pharmaceutical Inc., approved by the US FDA.
What are the ingredients of Vimizim?
Vimizim contains Elosulfase Alfa (5 mg/5mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA